Monday, August 24, 2026

HomeHealth NewsA polygenic risk score may predict future breast cancer in patients with...

A polygenic risk score may predict future breast cancer in patients with early-stage diagnoses

- Advertisement -

Credit: Pixabay/CC0 Public Domain

A retrospective study found that the 313-SNP breast cancer polygenic risk score (PRS313) blood test could predict future incidents of breast cancer in women diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS).

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed